Cargando…

Targeting p85β nuclear translocation for the tumors with PIK3CA helical domain mutations

Detalles Bibliográficos
Autores principales:	He, Baoyu, Hao, Yujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485267/ https://www.ncbi.nlm.nih.gov/pubmed/36157480 http://dx.doi.org/10.1016/j.gendis.2022.05.018

Ejemplares similares

Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer
por: Hao, Yujun, et al.
Publicado: (2022)

Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer
por: Vatte, Chittibabu, et al.
Publicado: (2019)

Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants
por: Ghodsinia, Arman Ali, et al.
Publicado: (2020)

Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesis
por: Wang, Ting, et al.
Publicado: (2023)

PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies
por: Tang, Yu, et al.
Publicado: (2020)

Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus
por: Jenkins, Meredith L., et al.
Publicado: (2023)

Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA
por: Garay, Joseph P., et al.
Publicado: (2021)

Targeting glutamine metabolism in PIK3CA mutant colorectal cancers
por: Feng, Xiujing, et al.
Publicado: (2016)

An RNA tertiary switch by modifying how helices are tethered
por: Ganser, Laura R, et al.
Publicado: (2014)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Alpelisib Plus Fulvestrant or Letrozole Demonstrates Sustained Benefits Across Subgroups of Patients with PIK3CA-Mutated HR+/HER2– Advanced Breast Cancer
por: Jacobson, Anne
Publicado: (2022)

Highlight: Old but Changeable—On the Family History of Nuclear Lamina
por: Venton, Danielle
Publicado: (2016)

WeiTsing: a new face of Ca(2+)-permeable channels in plant immunity
por: Wang, Feng-Zhu, et al.
Publicado: (2023)

NADase and now Ca(2+) channel, what else to learn about plant NLRs?
por: Wan, Li, et al.
Publicado: (2021)

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Hao, Yujun, et al.
Publicado: (2016)

Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

PIK3CA Mutations in Hepatocellular Carcinoma in Korea
por: Kim, Heesue, et al.
Publicado: (2013)

PIK3CA Mutational Analysis of Parathyroid Adenomas
por: Riccardi, Aaliyah, et al.
Publicado: (2020)

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
por: Deshpande, Vikram, et al.
Publicado: (2011)

Induction of membraneless organelles as a strategy for HIV-1 post-nuclear entry steps
por: Zhou, Sheng, et al.
Publicado: (2023)

Ca(2+) signaling in plant manganese uptake: CPK21/23 kinases phosphorylate and activate manganese transporter NRAMP1
por: Huang, Chao-Feng
Publicado: (2022)

Composites with high omnidirectional fracture toughness due to helical interlocking fasteners are found in gingko seed shells
por: Kotov, Nicholas A
Publicado: (2023)

Highlight: Not Like a Textbook—Nuclear Genes in Blastocystis Use mRNA Polyadenylation for Stop Codons
por: Venton, Danielle
Publicado: (2014)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
por: Janku, Filip, et al.
Publicado: (2012)

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
por: Madsen, Ralitsa R., et al.
Publicado: (2018)

PIK3CA mutation and colorectal cancer precision medicine
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
por: Hutchinson, Katherine E., et al.
Publicado: (2023)

Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer
por: Mazloumi Gavgani, Fatemeh, et al.
Publicado: (2018)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Adagrasib: A landmark in the KRAS(G12C)‐mutated NSCLC
por: Tian, He, et al.
Publicado: (2022)

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
por: Palimaru, Irina, et al.
Publicado: (2013)

A Mosaic PIK3CA Mutation in a Moroccan Female: Exploring the Diagnostic Challenges of PIK3CA-Related Overgrowth Spectrum
por: Ahakoud, Mohamed, et al.
Publicado: (2023)

Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer
por: Kodahl, Annette R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5n40f3tg52aus8emtmvs0ho0jg